Viewing Study NCT00126568


Ignite Creation Date: 2025-12-24 @ 5:37 PM
Ignite Modification Date: 2026-02-26 @ 4:13 PM
Study NCT ID: NCT00126568
Status: TERMINATED
Last Update Posted: 2018-01-19
First Post: 2005-08-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anaplastic Thyroid Cancer View
None Recurrent Thyroid Cancer View
Keywords: